No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
SKYE SKYE BIOSCIENCE INC
- 2.700
- -0.160-5.59%
Close Dec 20 16:00 ET
- 2.700
- 0.000-0.01%
Post 20:01 ET
81.91MMarket Cap5.09P/E (TTM)
3.090High2.660Low484.73KVolume2.850Open2.860Pre Close1.34MTurnover3.20%Turnover RatioLossP/E (Static)30.34MShares19.41052wk High1.08P/B40.87MFloat Cap2.25052wk Low--Dividend TTM15.14MShs Float64.725Historical High--Div YieldTTM15.04%Amplitude1.440Historical Low2.754Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Give the Gift of Emotional Growth This Holiday Season
Skye Bioscience to Participate in Upcoming December Healthcare Investment Conferences
Craig-Hallum Maintains SKYE BIOSCIENCE INC(SKYE.US) With Buy Rating
Express News | Skye Bioscience Inc - Expects Interim Data for Cbeyond Phase 2 Trial in Q2 2025
Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor
Oppenheimer Maintains SKYE BIOSCIENCE INC(SKYE.US) With Buy Rating, Maintains Target Price $21
Heat List
US
Overall
Symbol
Price
% Chg
No Data